The latest report by IMARC Group, titled “Array Instruments Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, offers a comprehensive analysis of the industry, which comprises insights on the global array instruments market report. The global market size reached US$ 1.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1.4 Billion by 2028, exhibiting a growth rate (CAGR) of 3.2% during 2023-2028.
Array instruments are devices that are used to collect microscopic spots of RNA, DNA, proteins, tissues, peptides, oligonucleotides, cells, and other compounds attached to a solid substrate. They are utilized in laboratories that quantitatively and simultaneously monitor the expression of multiple genes. The high-throughput approach of array technology helps to locate mutations and chromosomal expressions in a genotype, and measure and detect gene expressions at the messenger RNA (mRNA) or the protein level.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/array-instruments-market/requestsample
Array Instruments Market Trends and Drivers:
The primary factors driving the array instruments market are the emerging need for diagnosing cancer, post-natal and different metabolic diseases. These instruments assist in hybridization, coupling biomolecules to a platform, sample preparation for detection, data analysis, and scanning, which have increased their demand in recent times. Furthermore, governments across the globe have undertaken several initiatives to improve the healthcare infrastructure and increase investments in research and development (R&D) activities, which in turn have boosted the demand for array instruments. Moreover, the introduction of the latest technologies, such as microarray-based comparative genomic hybridization, has enhanced the process of single nucleotide polymorphism (SNP) and offers accuracy and precision in disease diagnosis and drug discovery, which in turn is expected to provide a positive impact on the industry.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Application:
- Molecular Biology
- Cell Biology
- Genetics
- Molecular Pathology
- Others
Breakup by Technology:
- DNA Microarrays
- Protein Microarrays
- Cellular Microarrays
- Tissue Microarrays
Breakup by End-User:
- Research and Development Laboratories
- Clinical Diagnostic Labs
- Agriculture Research Centers
- Veterinary Laboratories
- Forensic Centers
- Others
Breakup by Region:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East & Africa
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
